Form 4 for TELA TELA Bio, Inc.
Accepted 2026-08-05 16:09:42 ET · period of report 2026-08-03 · accession 0001481485-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-05 16:09 | 2026-08-03 | TELA | Getz Heather C | CEO, Dir | A - Grant | $0.00 | +500.0K | 505.0K | +10,000% | $0 |
| DM | 2026-08-05 16:09 | 2026-08-03 | TELA | Getz Heather C | CEO, Dir | A - Grant | $0.00 | +2.37M | 1.00M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-03 | A | A | 500,000 | $0.00 | 505,000 | D | — | — | (F1) These restricted stock units will vest in four equal annual installments beginning on August 3, 2027, in each case subject to the Reporting Person's continued service through the applicable vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-08-03 | A | A | 1,365,000 | $0.00 | 1,365,000 | D | $0.74 · — to 2036-08-03 | 1,365,000 Common Stock | (F2) The option vests 25% on August 3, 2027, with the remaining 75% vesting in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service through the applicable vesting dates. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-08-03 | A | A | 1,005,000 | $0.00 | 1,005,000 | D | $0.9 · — to 2036-08-03 | 1,005,000 Common Stock | (F2) The option vests 25% on August 3, 2027, with the remaining 75% vesting in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service through the applicable vesting dates. |